Arbaclofen placarbil is an oral prodrug formulation tested in immediate-release, sustained-release and modified-release tablet and capsule forms. It is studied in gastroesophageal reflux disease, alcohol use disorder and healthy volunteers.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.